Oppenheimer Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $9.00
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) had its price objective decreased by stock analysts at Oppenheimer from $15.00 to $9.00 in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Oppenheimer’s target price suggests a potential upside of 480.65% from the […]
ProQR Therapeutics (NASDAQ:PRQR – Get Free Report) had its price objective decreased by stock analysts at Oppenheimer from $15.00 to $9.00 in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Oppenheimer’s target price suggests a potential upside of 480.65% from the […]
